Evaluating markers for the early detection of cancer: overview of study designs and methods (Q36421984)

14 August 2017

1 reference

title

Evaluating markers for the early detection of cancer: overview of study designs and methods (English)

1 reference

early detection of cancer

14 August 2017

1 reference

Stuart G Baker

1

1 reference

14 August 2017

Barnett S Kramer

2

1 reference

14 August 2017

Martin McIntosh

3

1 reference

14 August 2017

Blossom H Patterson

4

1 reference

14 August 2017

Yu Shyr

5

1 reference

14 August 2017

Steven Skates

6

1 reference

14 August 2017

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

3

1 reference

14 August 2017

1

1 reference

14 August 2017

43-56

1 reference

Identifying combinations of cancer markers for further study as triggers of early intervention

14 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Phases of biomarker development for early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

The case for early detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Development tracks for cancer prevention markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Methylation changes in faecal DNA: a marker for colorectal cancer screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Detection of APC mutations in fecal DNA from patients with colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Markers for early detection of cancer: statistical guidelines for nested case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Combining biomarkers to detect disease with application to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Combining several screening tests: optimality of the risk score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Combining diagnostic test results to increase accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

On linear combinations of biomarkers to improve diagnostic accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Selecting Differentially Expressed Genes from Microarray Experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Overview of commonly used bioinformatics methods and their applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Problems of spectrum and bias in evaluating the efficacy of diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Emergentism as a default: cancer as a problem of tissue organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Statistical models for longitudinal biomarkers of disease onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Bias as a threat to the validity of cancer molecular-marker research

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Evaluating serial observations of precancerous lesions for further study as a trigger for early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Accuracy of screening mammography interpretation by characteristics of radiologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Physician predictors of mammographic accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Estimating the sensitivity of a screening test

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Evaluating multiple diagnostic tests with partial verification

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Partial AUC Estimation and Regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Comparing new and old screening tests when a reference procedure cannot be performed on all screenees. Example of automated cytometry for early detection of cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Statistical issues in randomized trials of cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Modelling the cumulative risk for a false-positive under repeated screening events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Estimating the cumulative risk of false positive cancer screenings

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Meta-analysis adjusting for compliance: the example of screening for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Case-control studies of cancer screening: theory and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

The case-control design and the assessment of the efficacy of cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Confounding by dietary factors in case-control studies on the efficacy of cancer screening in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Statistical models for cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Diversity of model approaches for breast cancer screening: a review of model assumptions by the Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Effect of screening and adjuvant therapy on mortality from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Survival results depend on the staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

Comparing breast cancer mortality rates before-and-after a change in availability of screening in different regions: extension of the paired availability design

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

The paired availability design: a proposal for evaluating epidural analgesia during labor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774506CN130OA

10.1191/1740774506CN130OA

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference